# COG-AHOD0431 (NCT00302003)

> Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00302003
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Children's Oncology Group
- Conditions: Childhood Favorable Prognosis Hodgkin Lymphoma; Childhood Lymphocyte Depletion Hodgkin Lymphoma; Childhood Mixed Cellularity Hodgkin Lymphoma; Childhood Nodular Sclerosis Hodgkin Lymphoma; Stage I Childhood Hodgkin Lymphoma; Stage II Childhood Hodgkin Lymphoma
- Interventions: radiation therapy; doxorubicin hydrochloride; vincristine sulfate; prednisone; cyclophosphamide; ifosfamide; vinorelbine tartrate; dexamethasone; etoposide phosphate; cisplatin; cytarabine; filgrastim
- Enrollment: 287
- Primary outcome: Event Free Survival Without Receiving Radiation Therapy (EFSnoRT).
- Primary outcome: Intensive Therapy Free Survival (ITFS).
- Primary outcome: Event Free Survival (EFS)

## Indexed commentary on COG-AHOD0431 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 6

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=cog-ahod0431-nct00302003